论文部分内容阅读
患者选择私人健康机构提供的筛查项目,如扫描和基因检测,会给自身带来不必要的风险,对健康无益。这是英国医学会(BMA)科学部简报的警告。许多人在进行检测前未被告之有潜在的风险,如全身磁共振成像(MRI)检查或前列腺癌特异性抗原检测。呼吁政府重视超出NHS正规筛查项目的不规范筛查而带来的问题。估计英国去年私人筛查已花费 6500万英镑(合1．17亿美元,0．95亿欧元)。
Patients who choose screening programs provided by private health institutions, such as scanning and genetic testing, will bring unnecessary risks to themselves and will not benefit their health. This is a warning from the briefing by the BMA Science Department. Many people have not been accused of potential risks prior to testing, such as whole body magnetic resonance imaging (MRI) or prostate cancer-specific antigen testing. Calls on the government to pay attention to the problems caused by the non-standard screening of the regular screening programs of the NHS. It is estimated that the private screening in the United Kingdom last year cost 65 million pounds (US$117 million, 95 million euros).